Literature DB >> 24961405

Pregnancy outcomes of prenatally diagnosed Turner syndrome: a French multicenter retrospective study including a series of 975 cases.

N Gruchy1, F Vialard, E Blondeel, N Le Meur, G Joly-Hélas, P Chambon, M Till, M Herbaut-Graux, A Vigouroux-Castera, A Coussement, J Lespinasse, F Amblard, M Jimenez, L Lebel Roy Camille, F Carré-Pigeon, E Flori, F Mugneret, S Jaillard, C Yardin, R Harbuz, M Collonge Rame, P Vago, M Valduga, N Leporrier.   

Abstract

OBJECTIVES: The objectives of this study were to report pregnancy outcomes after prenatal diagnosis of Turner syndrome (TS) and to compare and assess termination of pregnancy rates during two periods. The intervals selected were before and after 1997 when multidisciplinary centers for prenatal diagnosis (MCPDs) were established in France.
METHODS: A database of 975 cases of TS diagnosed between 1980 and 2012 was created from 21 French cytogenetics laboratories. For each case, the karyotype indication, maternal age, year of prenatal testing, sampling procedure, karyotype, associated ultrasound findings, and outcomes were recorded.
RESULTS: Karyotypes were mainly performed because of abnormal sonographic findings (84%). Before 1997, there were no changes in the rate of termination (90%) of affected fetuses. After 1997, the rate fell to 80%. This decrease was mainly observed in cases of mosaicism, incidental diagnosis, and in later gestations. US abnormalities were more likely to be associated with a full 45,X karyotype.
CONCLUSION: There was an evolution in the way genetic counseling was performed following prenatal diagnosis of Turner syndrome that coincided with the opening of MCPDs in France. This resulted in a decrease in the rate of termination of affected fetuses.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24961405     DOI: 10.1002/pd.4439

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Turner syndrome - The clinical spectrum and management dilemmas.

Authors:  Krishanthy Thayalan; Kimberly Chung; Alka Kothari
Journal:  Australas J Ultrasound Med       Date:  2018-06-21

2.  Clinical features and pregnancy outcomes of women with abnormal cell-free fetal DNA test results.

Authors:  Qin Zhou; Zhi-Ping Zhu; Bin Zhang; Bin Yu; Zheng-Mao Cai; Pei Yuan
Journal:  Ann Transl Med       Date:  2019-07

3.  Noninvasive prenatal testing for assessing foetal sex chromosome aneuploidy: a retrospective study of 45,773 cases.

Authors:  Xinran Lu; Chaohong Wang; Yuxiu Sun; Junxiang Tang; Keting Tong; Jiansheng Zhu
Journal:  Mol Cytogenet       Date:  2021-01-06       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.